Gain (Loss) on Sale of Assets and Asset Impairment Charges
Johnson & Johnson Gain (Loss) on Sale of Assets and Asset Impairment Charges decreased by 109.1% to -$12.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 116.0%, from $75.00M to -$12.00M. Over 4 years (FY 2021 to FY 2025), Gain (Loss) on Sale of Assets and Asset Impairment Charges shows a downward trend with a -19.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
Frequent losses may indicate poor asset management or structural decline in specific business units.
Detailed definition
This captures the net impact of gains or losses realized from the disposal of assets, alongside any impairment charges r...
Peer comparison
Varies significantly based on corporate portfolio optimization and divestiture cycles.
operating_gain_loss_on_sales_of_assets_and_asset_impairm_2fb394Historical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $21.00M | $0.00 | $16.00M | $168.00M | $45.00M | $0.00 | $167.00M | $8.00M | $39.00M | $70.00M | $0.00 | $0.00 | $223.00M | $2.00M | $1.00M | $75.00M | $0.00 | $57.00M | $132.00M | -$12.00M |
| QoQ Change | — | -100.0% | — | +950.0% | -73.2% | -100.0% | — | -95.2% | +387.5% | +79.5% | -100.0% | — | — | -99.1% | -50.0% | >999% | -100.0% | — | +131.6% | -109.1% |
| YoY Change | — | — | — | — | +114.3% | — | +943.8% | -95.2% | -13.3% | — | -100.0% | -100.0% | +471.8% | -97.1% | — | — | -100.0% | >999% | >999% | -116.0% |
Gain (Loss) on Sale of Assets and Asset Impairment Charges at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's gain (loss) on sale of assets and asset impairment charges?
- Johnson & Johnson (JNJ) reported gain (loss) on sale of assets and asset impairment charges of -$12.00M in Q1 2026.
- How has Johnson & Johnson's gain (loss) on sale of assets and asset impairment charges changed year-over-year?
- Johnson & Johnson's gain (loss) on sale of assets and asset impairment charges decreased by 116.0% year-over-year, from $75.00M to -$12.00M.
- What is the long-term trend for Johnson & Johnson's gain (loss) on sale of assets and asset impairment charges?
- Over 4 years (2021 to 2025), Johnson & Johnson's gain (loss) on sale of assets and asset impairment charges has grown at a -19.1% compound annual growth rate (CAGR), from $617.00M to $264.00M.
- What does gain (loss) on sale of assets and asset impairment charges mean?
- The net profit or loss resulting from selling assets or writing down their value.